nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCG2—Vandetanib—thyroid cancer	0.153	0.233	CbGbCtD
Hydrocortisone—ABCG2—Sorafenib—thyroid cancer	0.0924	0.141	CbGbCtD
Hydrocortisone—CYP3A7—Sorafenib—thyroid cancer	0.0683	0.104	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0683	0.104	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—thyroid cancer	0.0561	0.0853	CbGbCtD
Hydrocortisone—CYP3A5—Sorafenib—thyroid cancer	0.0512	0.0779	CbGbCtD
Hydrocortisone—CYP2C8—Sorafenib—thyroid cancer	0.0492	0.0749	CbGbCtD
Hydrocortisone—ABCB1—Sorafenib—thyroid cancer	0.0333	0.0507	CbGbCtD
Hydrocortisone—CYP3A4—Vandetanib—thyroid cancer	0.0331	0.0504	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—thyroid cancer	0.0202	0.0308	CbGbCtD
Hydrocortisone—CYP3A4—Sorafenib—thyroid cancer	0.02	0.0304	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—thyroid cancer	0.0121	0.0184	CbGbCtD
Hydrocortisone—ANXA1—neck—thyroid cancer	0.00248	0.135	CbGeAlD
Hydrocortisone—ANXA1—saliva-secreting gland—thyroid cancer	0.00193	0.106	CbGeAlD
Hydrocortisone—SHBG—neck—thyroid cancer	0.00166	0.0904	CbGeAlD
Hydrocortisone—ANXA1—trachea—thyroid cancer	0.00149	0.0814	CbGeAlD
Hydrocortisone—ANXA1—thyroid gland—thyroid cancer	0.00118	0.0644	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—thyroid cancer	0.00107	0.0587	CbGeAlD
Hydrocortisone—ANXA1—head—thyroid cancer	0.00105	0.0571	CbGeAlD
Hydrocortisone—NR3C1—neck—thyroid cancer	0.000861	0.047	CbGeAlD
Hydrocortisone—SHBG—thyroid gland—thyroid cancer	0.000788	0.043	CbGeAlD
Hydrocortisone—ANXA1—lymph node—thyroid cancer	0.000733	0.04	CbGeAlD
Hydrocortisone—ABCG2—saliva-secreting gland—thyroid cancer	0.000729	0.0398	CbGeAlD
Hydrocortisone—Glycosuria—Epirubicin—thyroid cancer	0.000683	0.00289	CcSEcCtD
Hydrocortisone—Stinging—Epirubicin—thyroid cancer	0.000683	0.00289	CcSEcCtD
Hydrocortisone—Fatigue—Vandetanib—thyroid cancer	0.000683	0.00289	CcSEcCtD
Hydrocortisone—Immune system disorder—Sorafenib—thyroid cancer	0.000679	0.00287	CcSEcCtD
Hydrocortisone—Pain—Vandetanib—thyroid cancer	0.000677	0.00286	CcSEcCtD
Hydrocortisone—Petechiae—Epirubicin—thyroid cancer	0.000673	0.00285	CcSEcCtD
Hydrocortisone—Arrhythmia—Sorafenib—thyroid cancer	0.000672	0.00284	CcSEcCtD
Hydrocortisone—NR3C1—saliva-secreting gland—thyroid cancer	0.000671	0.0366	CbGeAlD
Hydrocortisone—Fungal infection—Doxorubicin—thyroid cancer	0.000663	0.0028	CcSEcCtD
Hydrocortisone—Mental disorder—Sorafenib—thyroid cancer	0.000659	0.00279	CcSEcCtD
Hydrocortisone—Malnutrition—Sorafenib—thyroid cancer	0.000654	0.00277	CcSEcCtD
Hydrocortisone—Erythema—Sorafenib—thyroid cancer	0.000654	0.00277	CcSEcCtD
Hydrocortisone—Necrosis—Doxorubicin—thyroid cancer	0.000652	0.00276	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000648	0.00274	CcSEcCtD
Hydrocortisone—Abscess—Doxorubicin—thyroid cancer	0.000647	0.00274	CcSEcCtD
Hydrocortisone—Stinging—Doxorubicin—thyroid cancer	0.000632	0.00267	CcSEcCtD
Hydrocortisone—Glycosuria—Doxorubicin—thyroid cancer	0.000632	0.00267	CcSEcCtD
Hydrocortisone—Amenorrhoea—Epirubicin—thyroid cancer	0.00063	0.00266	CcSEcCtD
Hydrocortisone—Abdominal pain—Vandetanib—thyroid cancer	0.000626	0.00265	CcSEcCtD
Hydrocortisone—Body temperature increased—Vandetanib—thyroid cancer	0.000626	0.00265	CcSEcCtD
Hydrocortisone—Petechiae—Doxorubicin—thyroid cancer	0.000622	0.00263	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Epirubicin—thyroid cancer	0.000613	0.00259	CcSEcCtD
Hydrocortisone—Viral infection—Epirubicin—thyroid cancer	0.000613	0.00259	CcSEcCtD
Hydrocortisone—Skin discolouration—Epirubicin—thyroid cancer	0.000613	0.00259	CcSEcCtD
Hydrocortisone—Arthropathy—Epirubicin—thyroid cancer	0.000608	0.00257	CcSEcCtD
Hydrocortisone—Angioedema—Sorafenib—thyroid cancer	0.000598	0.00253	CcSEcCtD
Hydrocortisone—Syncope—Sorafenib—thyroid cancer	0.000587	0.00248	CcSEcCtD
Hydrocortisone—Amenorrhoea—Doxorubicin—thyroid cancer	0.000583	0.00246	CcSEcCtD
Hydrocortisone—SLCO1A2—head—thyroid cancer	0.000581	0.0317	CbGeAlD
Hydrocortisone—Loss of consciousness—Sorafenib—thyroid cancer	0.000575	0.00243	CcSEcCtD
Hydrocortisone—Inflammation—Epirubicin—thyroid cancer	0.00057	0.00241	CcSEcCtD
Hydrocortisone—Asthenia—Vandetanib—thyroid cancer	0.000568	0.0024	CcSEcCtD
Hydrocortisone—Viral infection—Doxorubicin—thyroid cancer	0.000567	0.0024	CcSEcCtD
Hydrocortisone—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.000567	0.0024	CcSEcCtD
Hydrocortisone—Skin discolouration—Doxorubicin—thyroid cancer	0.000567	0.0024	CcSEcCtD
Hydrocortisone—Hypertension—Sorafenib—thyroid cancer	0.000565	0.00239	CcSEcCtD
Hydrocortisone—Arthropathy—Doxorubicin—thyroid cancer	0.000563	0.00238	CcSEcCtD
Hydrocortisone—Pruritus—Vandetanib—thyroid cancer	0.00056	0.00237	CcSEcCtD
Hydrocortisone—Myalgia—Sorafenib—thyroid cancer	0.000557	0.00236	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000553	0.00234	CcSEcCtD
Hydrocortisone—Hiccups—Epirubicin—thyroid cancer	0.000553	0.00234	CcSEcCtD
Hydrocortisone—Dermatitis contact—Epirubicin—thyroid cancer	0.000547	0.00231	CcSEcCtD
Hydrocortisone—Diarrhoea—Vandetanib—thyroid cancer	0.000542	0.00229	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000534	0.00226	CcSEcCtD
Hydrocortisone—Infection—Sorafenib—thyroid cancer	0.000531	0.00224	CcSEcCtD
Hydrocortisone—Skin exfoliation—Epirubicin—thyroid cancer	0.000528	0.00223	CcSEcCtD
Hydrocortisone—Inflammation—Doxorubicin—thyroid cancer	0.000528	0.00223	CcSEcCtD
Hydrocortisone—Shock—Sorafenib—thyroid cancer	0.000526	0.00222	CcSEcCtD
Hydrocortisone—Fluid retention—Epirubicin—thyroid cancer	0.000525	0.00222	CcSEcCtD
Hydrocortisone—Nervous system disorder—Sorafenib—thyroid cancer	0.000524	0.00222	CcSEcCtD
Hydrocortisone—Dizziness—Vandetanib—thyroid cancer	0.000524	0.00222	CcSEcCtD
Hydrocortisone—Neuropathy—Epirubicin—thyroid cancer	0.000519	0.0022	CcSEcCtD
Hydrocortisone—Skin disorder—Sorafenib—thyroid cancer	0.000519	0.00219	CcSEcCtD
Hydrocortisone—NR3C1—trachea—thyroid cancer	0.000518	0.0283	CbGeAlD
Hydrocortisone—Hiccups—Doxorubicin—thyroid cancer	0.000512	0.00217	CcSEcCtD
Hydrocortisone—Dry eye—Epirubicin—thyroid cancer	0.000511	0.00216	CcSEcCtD
Hydrocortisone—Anorexia—Sorafenib—thyroid cancer	0.000509	0.00215	CcSEcCtD
Hydrocortisone—Dermatitis contact—Doxorubicin—thyroid cancer	0.000506	0.00214	CcSEcCtD
Hydrocortisone—Oesophagitis—Epirubicin—thyroid cancer	0.000506	0.00214	CcSEcCtD
Hydrocortisone—Vomiting—Vandetanib—thyroid cancer	0.000503	0.00213	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Epirubicin—thyroid cancer	0.000503	0.00213	CcSEcCtD
Hydrocortisone—Ecchymosis—Epirubicin—thyroid cancer	0.0005	0.00212	CcSEcCtD
Hydrocortisone—Rash—Vandetanib—thyroid cancer	0.000499	0.00211	CcSEcCtD
Hydrocortisone—Dermatitis—Vandetanib—thyroid cancer	0.000499	0.00211	CcSEcCtD
Hydrocortisone—Headache—Vandetanib—thyroid cancer	0.000496	0.0021	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000493	0.00208	CcSEcCtD
Hydrocortisone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000489	0.00207	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000487	0.00206	CcSEcCtD
Hydrocortisone—Fluid retention—Doxorubicin—thyroid cancer	0.000486	0.00206	CcSEcCtD
Hydrocortisone—Neuropathy—Doxorubicin—thyroid cancer	0.000481	0.00203	CcSEcCtD
Hydrocortisone—Dry eye—Doxorubicin—thyroid cancer	0.000473	0.002	CcSEcCtD
Hydrocortisone—Nausea—Vandetanib—thyroid cancer	0.00047	0.00199	CcSEcCtD
Hydrocortisone—Dyspepsia—Sorafenib—thyroid cancer	0.00047	0.00199	CcSEcCtD
Hydrocortisone—Oesophagitis—Doxorubicin—thyroid cancer	0.000468	0.00198	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000465	0.00197	CcSEcCtD
Hydrocortisone—Decreased appetite—Sorafenib—thyroid cancer	0.000464	0.00196	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Epirubicin—thyroid cancer	0.000464	0.00196	CcSEcCtD
Hydrocortisone—Ecchymosis—Doxorubicin—thyroid cancer	0.000463	0.00196	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Epirubicin—thyroid cancer	0.000462	0.00195	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000461	0.00195	CcSEcCtD
Hydrocortisone—Fatigue—Sorafenib—thyroid cancer	0.000461	0.00195	CcSEcCtD
Hydrocortisone—Pain—Sorafenib—thyroid cancer	0.000457	0.00193	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000456	0.00193	CcSEcCtD
Hydrocortisone—Eczema—Epirubicin—thyroid cancer	0.000447	0.00189	CcSEcCtD
Hydrocortisone—ABCG2—thyroid gland—thyroid cancer	0.000445	0.0243	CbGeAlD
Hydrocortisone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000443	0.00187	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000437	0.00185	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000429	0.00182	CcSEcCtD
Hydrocortisone—Increased appetite—Epirubicin—thyroid cancer	0.000428	0.00181	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000427	0.00181	CcSEcCtD
Hydrocortisone—Urticaria—Sorafenib—thyroid cancer	0.000424	0.0018	CcSEcCtD
Hydrocortisone—Body temperature increased—Sorafenib—thyroid cancer	0.000422	0.00179	CcSEcCtD
Hydrocortisone—Abdominal pain—Sorafenib—thyroid cancer	0.000422	0.00179	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000415	0.00176	CcSEcCtD
Hydrocortisone—Eczema—Doxorubicin—thyroid cancer	0.000414	0.00175	CcSEcCtD
Hydrocortisone—Cardiac failure—Epirubicin—thyroid cancer	0.000412	0.00174	CcSEcCtD
Hydrocortisone—Lethargy—Epirubicin—thyroid cancer	0.00041	0.00173	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00041	0.00173	CcSEcCtD
Hydrocortisone—NR3C1—thyroid gland—thyroid cancer	0.00041	0.0224	CbGeAlD
Hydrocortisone—Osteoarthritis—Epirubicin—thyroid cancer	0.000402	0.0017	CcSEcCtD
Hydrocortisone—Increased appetite—Doxorubicin—thyroid cancer	0.000396	0.00167	CcSEcCtD
Hydrocortisone—Affect lability—Epirubicin—thyroid cancer	0.000395	0.00167	CcSEcCtD
Hydrocortisone—Hypersensitivity—Sorafenib—thyroid cancer	0.000394	0.00166	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000384	0.00162	CcSEcCtD
Hydrocortisone—Asthenia—Sorafenib—thyroid cancer	0.000383	0.00162	CcSEcCtD
Hydrocortisone—Cardiac arrest—Epirubicin—thyroid cancer	0.000382	0.00162	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—thyroid cancer	0.000381	0.00161	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—thyroid cancer	0.00038	0.00161	CcSEcCtD
Hydrocortisone—Lethargy—Doxorubicin—thyroid cancer	0.000379	0.0016	CcSEcCtD
Hydrocortisone—Pruritus—Sorafenib—thyroid cancer	0.000378	0.0016	CcSEcCtD
Hydrocortisone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000372	0.00157	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—thyroid cancer	0.000368	0.00156	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Epirubicin—thyroid cancer	0.000367	0.00155	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—thyroid cancer	0.000366	0.00155	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—thyroid cancer	0.000366	0.00155	CcSEcCtD
Hydrocortisone—Diarrhoea—Sorafenib—thyroid cancer	0.000365	0.00155	CcSEcCtD
Hydrocortisone—NR3C1—head—thyroid cancer	0.000363	0.0198	CbGeAlD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000354	0.0015	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—thyroid cancer	0.000354	0.0015	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000353	0.00149	CcSEcCtD
Hydrocortisone—Dizziness—Sorafenib—thyroid cancer	0.000353	0.00149	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—thyroid cancer	0.000352	0.00149	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—thyroid cancer	0.000349	0.00148	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—thyroid cancer	0.000341	0.00144	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—thyroid cancer	0.00034	0.00144	CcSEcCtD
Hydrocortisone—Vomiting—Sorafenib—thyroid cancer	0.00034	0.00144	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000339	0.00144	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000338	0.00143	CcSEcCtD
Hydrocortisone—Rash—Sorafenib—thyroid cancer	0.000337	0.00142	CcSEcCtD
Hydrocortisone—Dermatitis—Sorafenib—thyroid cancer	0.000336	0.00142	CcSEcCtD
Hydrocortisone—Headache—Sorafenib—thyroid cancer	0.000335	0.00142	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—thyroid cancer	0.000328	0.00139	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000328	0.00139	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—thyroid cancer	0.000323	0.00137	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000323	0.00136	CcSEcCtD
Hydrocortisone—Nausea—Sorafenib—thyroid cancer	0.000317	0.00134	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—thyroid cancer	0.000316	0.00134	CcSEcCtD
Hydrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000315	0.00361	CbGpPWpGaD
Hydrocortisone—Pancreatitis—Doxorubicin—thyroid cancer	0.000315	0.00133	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—thyroid cancer	0.000314	0.00133	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000313	0.00359	CbGpPWpGaD
Hydrocortisone—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000312	0.00357	CbGpPWpGaD
Hydrocortisone—Infestation—Epirubicin—thyroid cancer	0.00031	0.00131	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—thyroid cancer	0.00031	0.00131	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000303	0.00128	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.0003	0.00343	CbGpPWpGaD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000299	0.00126	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000298	0.00341	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CALCB—thyroid cancer	0.000293	0.00336	CbGpPWpGaD
Hydrocortisone—Weight increased—Doxorubicin—thyroid cancer	0.000292	0.00124	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—thyroid cancer	0.000291	0.00123	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000288	0.00329	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000287	0.00329	CbGpPWpGaD
Hydrocortisone—Infestation—Doxorubicin—thyroid cancer	0.000286	0.00121	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—thyroid cancer	0.000286	0.00121	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—thyroid cancer	0.000283	0.0012	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000281	0.00321	CbGpPWpGaD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000281	0.00119	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—thyroid cancer	0.000279	0.00118	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—TRIM33—thyroid cancer	0.000278	0.00318	CbGpPWpGaD
Hydrocortisone—Haemorrhage—Epirubicin—thyroid cancer	0.000278	0.00118	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—MINPP1—thyroid cancer	0.000278	0.00318	CbGpPWpGaD
Hydrocortisone—ABCB1—trachea—thyroid cancer	0.000277	0.0151	CbGeAlD
Hydrocortisone—ABCG2—lymph node—thyroid cancer	0.000276	0.0151	CbGeAlD
Hydrocortisone—CYP11B2—Metabolism—NDUFA13—thyroid cancer	0.000274	0.00313	CbGpPWpGaD
Hydrocortisone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000273	0.00116	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000273	0.00312	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000272	0.00312	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000271	0.0031	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000271	0.0031	CbGpPWpGaD
Hydrocortisone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00027	0.00309	CbGpPWpGaD
Hydrocortisone—Bradycardia—Doxorubicin—thyroid cancer	0.000262	0.00111	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—thyroid cancer	0.00026	0.0011	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—thyroid cancer	0.000258	0.00109	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—CHST14—thyroid cancer	0.000258	0.00295	CbGpPWpGaD
Hydrocortisone—Haemorrhage—Doxorubicin—thyroid cancer	0.000257	0.00109	CcSEcCtD
Hydrocortisone—NR3C1—lymph node—thyroid cancer	0.000254	0.0139	CbGeAlD
Hydrocortisone—ANXA1—GPCR downstream signaling—TSHR—thyroid cancer	0.000253	0.0029	CbGpPWpGaD
Hydrocortisone—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000253	0.0029	CbGpPWpGaD
Hydrocortisone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000253	0.00107	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000252	0.00289	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000252	0.00288	CbGpPWpGaD
Hydrocortisone—Immune system disorder—Epirubicin—thyroid cancer	0.000251	0.00106	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—thyroid cancer	0.000248	0.00105	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000247	0.00282	CbGpPWpGaD
Hydrocortisone—Mental disorder—Epirubicin—thyroid cancer	0.000243	0.00103	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—thyroid cancer	0.000242	0.00102	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—thyroid cancer	0.000242	0.00102	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—thyroid cancer	0.00024	0.00102	CcSEcCtD
Hydrocortisone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00024	0.00275	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—thyroid cancer	0.000239	0.00273	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000238	0.00272	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000236	0.0027	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—NDUFA13—thyroid cancer	0.000236	0.0027	CbGpPWpGaD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000234	0.00268	CbGpPWpGaD
Hydrocortisone—Immune system disorder—Doxorubicin—thyroid cancer	0.000232	0.000982	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—TSHR—thyroid cancer	0.00023	0.00263	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Doxorubicin—thyroid cancer	0.00023	0.000972	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000226	0.00259	CbGpPWpGaD
Hydrocortisone—Mental disorder—Doxorubicin—thyroid cancer	0.000225	0.000953	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000224	0.000949	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—thyroid cancer	0.000224	0.000947	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—thyroid cancer	0.000224	0.000947	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—CHST14—thyroid cancer	0.000222	0.00254	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000221	0.00252	CbGpPWpGaD
Hydrocortisone—ABCB1—thyroid gland—thyroid cancer	0.000219	0.012	CbGeAlD
Hydrocortisone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000219	0.00251	CbGpPWpGaD
Hydrocortisone—Malaise—Epirubicin—thyroid cancer	0.000218	0.000923	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—thyroid cancer	0.000217	0.000919	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—thyroid cancer	0.000217	0.000918	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—thyroid cancer	0.000213	0.000899	CcSEcCtD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000212	0.00242	CbGpPWpGaD
Hydrocortisone—Convulsion—Epirubicin—thyroid cancer	0.00021	0.000887	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—thyroid cancer	0.000209	0.000883	CcSEcCtD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000208	0.00238	CbGpPWpGaD
Hydrocortisone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000208	0.000878	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—HPGD—thyroid cancer	0.000208	0.00238	CbGpPWpGaD
Hydrocortisone—Myalgia—Epirubicin—thyroid cancer	0.000206	0.000871	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—thyroid cancer	0.000205	0.000868	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000205	0.000865	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—thyroid cancer	0.000203	0.000861	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000203	0.00232	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000203	0.00232	CbGpPWpGaD
Hydrocortisone—Malaise—Doxorubicin—thyroid cancer	0.000202	0.000854	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—thyroid cancer	0.000201	0.000851	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—thyroid cancer	0.000201	0.000849	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—thyroid cancer	0.000197	0.000835	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000197	0.000835	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—SST—thyroid cancer	0.000197	0.00225	CbGpPWpGaD
Hydrocortisone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000197	0.000832	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—thyroid cancer	0.000196	0.00083	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000196	0.00224	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—PTCH1—thyroid cancer	0.000195	0.00224	CbGpPWpGaD
Hydrocortisone—ABCB1—head—thyroid cancer	0.000195	0.0106	CbGeAlD
Hydrocortisone—Shock—Epirubicin—thyroid cancer	0.000194	0.000822	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—thyroid cancer	0.000194	0.00082	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—thyroid cancer	0.000194	0.000819	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—thyroid cancer	0.000193	0.000817	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000193	0.00221	CbGpPWpGaD
Hydrocortisone—Tachycardia—Epirubicin—thyroid cancer	0.000193	0.000815	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—thyroid cancer	0.000192	0.000811	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000191	0.000807	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—thyroid cancer	0.000191	0.000806	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—thyroid cancer	0.00019	0.000803	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—CALCA—thyroid cancer	0.00019	0.00217	CbGpPWpGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000189	0.000801	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—thyroid cancer	0.000188	0.000796	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—thyroid cancer	0.000188	0.000796	CcSEcCtD
Hydrocortisone—CYP3A7—Biological oxidations—RXRA—thyroid cancer	0.000186	0.00213	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TCF7L1—thyroid cancer	0.000186	0.00212	CbGpPWpGaD
Hydrocortisone—Hypotension—Epirubicin—thyroid cancer	0.000184	0.00078	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000183	0.00209	CbGpPWpGaD
Hydrocortisone—Oedema—Doxorubicin—thyroid cancer	0.000183	0.000773	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000183	0.000773	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—thyroid cancer	0.000181	0.000768	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00018	0.000761	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—thyroid cancer	0.00018	0.00076	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000179	0.000758	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—HPGD—thyroid cancer	0.000179	0.00205	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—SST—thyroid cancer	0.000179	0.00205	CbGpPWpGaD
Hydrocortisone—Insomnia—Epirubicin—thyroid cancer	0.000179	0.000755	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—thyroid cancer	0.000178	0.000754	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—thyroid cancer	0.000177	0.000751	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—thyroid cancer	0.000177	0.00075	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000177	0.000747	CcSEcCtD
Hydrocortisone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000175	0.00201	CbGpPWpGaD
Hydrocortisone—Anorexia—Doxorubicin—thyroid cancer	0.000174	0.000737	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000174	0.00199	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000174	0.00199	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Epirubicin—thyroid cancer	0.000174	0.000735	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—CALCA—thyroid cancer	0.000172	0.00197	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Epirubicin—thyroid cancer	0.000172	0.000726	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—thyroid cancer	0.000171	0.000722	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00017	0.000721	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—thyroid cancer	0.00017	0.00072	CcSEcCtD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000169	0.00194	CbGpPWpGaD
Hydrocortisone—Pain—Epirubicin—thyroid cancer	0.000169	0.000714	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000168	0.00193	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000168	0.00192	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000166	0.000704	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000166	0.0019	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000166	0.00189	CbGpPWpGaD
Hydrocortisone—Insomnia—Doxorubicin—thyroid cancer	0.000165	0.000699	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—thyroid cancer	0.000164	0.000694	CcSEcCtD
Hydrocortisone—Feeling abnormal—Epirubicin—thyroid cancer	0.000163	0.000688	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000162	0.00186	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000162	0.00185	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000161	0.000683	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—thyroid cancer	0.000161	0.00068	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—thyroid cancer	0.000159	0.000672	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000158	0.000667	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—thyroid cancer	0.000157	0.000666	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—thyroid cancer	0.000157	0.000663	CcSEcCtD
Hydrocortisone—Pain—Doxorubicin—thyroid cancer	0.000156	0.000661	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—thyroid cancer	0.000156	0.00066	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—thyroid cancer	0.000156	0.00066	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—CDK1—thyroid cancer	0.000156	0.00178	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000156	0.00178	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000155	0.00178	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000152	0.00173	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000151	0.000637	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000149	0.000632	CcSEcCtD
Hydrocortisone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000149	0.00171	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000148	0.00169	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Epirubicin—thyroid cancer	0.000145	0.000615	CcSEcCtD
Hydrocortisone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000145	0.00166	CbGpPWpGaD
Hydrocortisone—Urticaria—Doxorubicin—thyroid cancer	0.000145	0.000614	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000145	0.00166	CbGpPWpGaD
Hydrocortisone—Body temperature increased—Doxorubicin—thyroid cancer	0.000144	0.000611	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—thyroid cancer	0.000144	0.000611	CcSEcCtD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000144	0.00165	CbGpPWpGaD
Hydrocortisone—Asthenia—Epirubicin—thyroid cancer	0.000142	0.000599	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000141	0.00162	CbGpPWpGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00014	0.00161	CbGpPWpGaD
Hydrocortisone—Pruritus—Epirubicin—thyroid cancer	0.00014	0.000591	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000139	0.00159	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000138	0.00158	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000138	0.00157	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000138	0.00157	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000137	0.00157	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—MINPP1—thyroid cancer	0.000137	0.00156	CbGpPWpGaD
Hydrocortisone—ABCB1—lymph node—thyroid cancer	0.000136	0.00744	CbGeAlD
Hydrocortisone—ANXA1—Signaling Pathways—TSHR—thyroid cancer	0.000136	0.00155	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000135	0.00155	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000135	0.00155	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Epirubicin—thyroid cancer	0.000135	0.000571	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000135	0.000569	CcSEcCtD
Hydrocortisone—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.000134	0.00154	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000134	0.00153	CbGpPWpGaD
Hydrocortisone—Asthenia—Doxorubicin—thyroid cancer	0.000131	0.000554	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—thyroid cancer	0.000131	0.000552	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—thyroid cancer	0.000129	0.000547	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000129	0.00148	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MEN1—thyroid cancer	0.000128	0.00146	CbGpPWpGaD
Hydrocortisone—Vomiting—Epirubicin—thyroid cancer	0.000126	0.000531	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—thyroid cancer	0.000125	0.000529	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—thyroid cancer	0.000124	0.000527	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—thyroid cancer	0.000124	0.000526	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000124	0.00142	CbGpPWpGaD
Hydrocortisone—Headache—Epirubicin—thyroid cancer	0.000124	0.000523	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—thyroid cancer	0.000121	0.000511	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—TPR—thyroid cancer	0.000119	0.00136	CbGpPWpGaD
Hydrocortisone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000118	0.00135	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PRKAR1A—thyroid cancer	0.000117	0.00134	CbGpPWpGaD
Hydrocortisone—Nausea—Epirubicin—thyroid cancer	0.000117	0.000496	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—NDUFA13—thyroid cancer	0.000117	0.00134	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000116	0.00133	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NDUFA13—thyroid cancer	0.000116	0.00133	CbGpPWpGaD
Hydrocortisone—Vomiting—Doxorubicin—thyroid cancer	0.000116	0.000491	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—PTCH1—thyroid cancer	0.000115	0.00132	CbGpPWpGaD
Hydrocortisone—Rash—Doxorubicin—thyroid cancer	0.000115	0.000487	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—thyroid cancer	0.000115	0.000487	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000115	0.00131	CbGpPWpGaD
Hydrocortisone—Headache—Doxorubicin—thyroid cancer	0.000114	0.000484	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000112	0.00128	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CHST14—thyroid cancer	0.00011	0.00126	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CHST14—thyroid cancer	0.000109	0.00125	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000109	0.00125	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000109	0.00125	CbGpPWpGaD
Hydrocortisone—Nausea—Doxorubicin—thyroid cancer	0.000108	0.000459	CcSEcCtD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000107	0.00123	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000106	0.00122	CbGpPWpGaD
Hydrocortisone—Drospirenone—PTGS2—thyroid cancer	0.000106	0.371	CrCbGaD
Hydrocortisone—ANXA1—Signaling Pathways—SST—thyroid cancer	0.000106	0.00121	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000103	0.00118	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TPR—thyroid cancer	0.000103	0.00118	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CALCA—thyroid cancer	0.000102	0.00116	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PRKAR1A—thyroid cancer	0.000101	0.00116	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000101	0.00116	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000101	0.00115	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—MINPP1—thyroid cancer	9.87e-05	0.00113	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—THRB—thyroid cancer	9.77e-05	0.00112	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	9.33e-05	0.00107	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CDK1—thyroid cancer	9.2e-05	0.00105	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.16e-05	0.00105	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	9.1e-05	0.00104	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—SLC5A5—thyroid cancer	8.92e-05	0.00102	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—HPGD—thyroid cancer	8.88e-05	0.00102	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—HPGD—thyroid cancer	8.8e-05	0.00101	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.65e-05	0.00099	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	8.62e-05	0.000987	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	8.61e-05	0.000985	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—MINPP1—thyroid cancer	8.55e-05	0.000979	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	8.52e-05	0.000976	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.4e-05	0.000961	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.36e-05	0.000957	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.15e-05	0.000933	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CHST14—thyroid cancer	7.89e-05	0.000903	CbGpPWpGaD
Hydrocortisone—Triamcinolone—PTGS2—thyroid cancer	7.82e-05	0.274	CrCbGaD
Hydrocortisone—CYP11B1—Metabolism—SLC5A5—thyroid cancer	7.69e-05	0.00088	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—RXRA—thyroid cancer	7.5e-05	0.000858	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—MINPP1—thyroid cancer	7.45e-05	0.000853	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRG1—thyroid cancer	7.39e-05	0.000845	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.29e-05	0.000835	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	7.27e-05	0.000832	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.21e-05	0.000825	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.85e-05	0.000784	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CHST14—thyroid cancer	6.84e-05	0.000783	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TERT—thyroid cancer	6.63e-05	0.000759	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—TPR—thyroid cancer	6.6e-05	0.000756	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—RXRA—thyroid cancer	6.46e-05	0.00074	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TPR—thyroid cancer	6.44e-05	0.000737	CbGpPWpGaD
Hydrocortisone—Betamethasone—PTGS2—thyroid cancer	6.41e-05	0.225	CrCbGaD
Hydrocortisone—CYP3A5—Metabolism—HPGD—thyroid cancer	6.36e-05	0.000728	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HIF1A—thyroid cancer	6.34e-05	0.000726	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	6.34e-05	0.000725	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NDUFA13—thyroid cancer	6.34e-05	0.000725	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.29e-05	0.000719	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.25e-05	0.000715	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MEN1—thyroid cancer	6.21e-05	0.00071	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CHST14—thyroid cancer	5.96e-05	0.000682	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.89e-05	0.000674	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.89e-05	0.000674	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.79e-05	0.000663	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.74e-05	0.000657	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—thyroid cancer	5.59e-05	0.00064	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HPGD—thyroid cancer	5.51e-05	0.000631	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.45e-05	0.000623	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	5.45e-05	0.000623	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—BRAF—thyroid cancer	5.25e-05	0.000601	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TPR—thyroid cancer	5.1e-05	0.000584	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TPR—thyroid cancer	5.06e-05	0.000579	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PRKAR1A—thyroid cancer	5.02e-05	0.000574	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	4.97e-05	0.000569	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	4.82e-05	0.000552	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—thyroid cancer	4.81e-05	0.00055	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HPGD—thyroid cancer	4.8e-05	0.00055	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PPARG—thyroid cancer	4.73e-05	0.000542	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.63e-05	0.00053	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.59e-05	0.000525	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.52e-05	0.000517	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.47e-05	0.000512	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.41e-05	0.000504	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.19e-05	0.000479	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—RXRA—thyroid cancer	4.15e-05	0.000475	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—thyroid cancer	4.09e-05	0.000468	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—thyroid cancer	4.08e-05	0.000467	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—RXRA—thyroid cancer	4.05e-05	0.000464	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	4.04e-05	0.000462	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AKT1—thyroid cancer	3.98e-05	0.000455	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.94e-05	0.000451	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.9e-05	0.000447	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—thyroid cancer	3.83e-05	0.000439	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.82e-05	0.000437	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.78e-05	0.000433	CbGpPWpGaD
Hydrocortisone—Dexamethasone—PTGS2—thyroid cancer	3.73e-05	0.131	CrCbGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—thyroid cancer	3.72e-05	0.000426	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.7e-05	0.000424	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PTEN—thyroid cancer	3.7e-05	0.000423	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CHST14—thyroid cancer	3.67e-05	0.00042	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TPR—thyroid cancer	3.65e-05	0.000418	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AKT1—thyroid cancer	3.61e-05	0.000413	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.6e-05	0.000411	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—thyroid cancer	3.3e-05	0.000378	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTEN—thyroid cancer	3.25e-05	0.000372	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—thyroid cancer	3.21e-05	0.000367	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—RXRA—thyroid cancer	3.21e-05	0.000367	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—RXRA—thyroid cancer	3.18e-05	0.000364	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TPR—thyroid cancer	3.17e-05	0.000362	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.11e-05	0.000356	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.1e-05	0.000355	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HPGD—thyroid cancer	2.96e-05	0.000339	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—thyroid cancer	2.84e-05	0.000325	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.82e-05	0.000323	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTEN—thyroid cancer	2.8e-05	0.00032	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TPR—thyroid cancer	2.76e-05	0.000316	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.76e-05	0.000316	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.74e-05	0.000313	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.71e-05	0.000311	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—thyroid cancer	2.62e-05	0.0003	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—thyroid cancer	2.56e-05	0.000293	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—thyroid cancer	2.53e-05	0.000289	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—thyroid cancer	2.42e-05	0.000276	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.37e-05	0.000271	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.33e-05	0.000266	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—RXRA—thyroid cancer	2.3e-05	0.000263	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.22e-05	0.000254	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AKT1—thyroid cancer	2.13e-05	0.000244	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SLC5A5—thyroid cancer	2.06e-05	0.000236	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—thyroid cancer	2.03e-05	0.000232	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—thyroid cancer	2.01e-05	0.00023	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—thyroid cancer	2.01e-05	0.00023	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—RXRA—thyroid cancer	1.99e-05	0.000228	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.94e-05	0.000222	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AKT1—thyroid cancer	1.87e-05	0.000214	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.76e-05	0.000201	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—RXRA—thyroid cancer	1.73e-05	0.000199	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TPR—thyroid cancer	1.7e-05	0.000194	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.67e-05	0.000191	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AKT1—thyroid cancer	1.61e-05	0.000185	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—thyroid cancer	1.59e-05	0.000182	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.58e-05	0.000181	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.45e-05	0.000166	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTEN—thyroid cancer	1.39e-05	0.000159	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTEN—thyroid cancer	1.38e-05	0.000158	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.27e-05	0.000146	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—thyroid cancer	1.26e-05	0.000144	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.14e-05	0.000131	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000125	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.07e-05	0.000122	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—AKT1—thyroid cancer	1.04e-05	0.000119	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AKT1—thyroid cancer	1.01e-05	0.000116	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTEN—thyroid cancer	9.96e-06	0.000114	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—thyroid cancer	9.89e-06	0.000113	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTEN—thyroid cancer	8.62e-06	9.87e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—thyroid cancer	8.62e-06	9.86e-05	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AKT1—thyroid cancer	8.01e-06	9.17e-05	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AKT1—thyroid cancer	7.94e-06	9.08e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTEN—thyroid cancer	7.51e-06	8.6e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—thyroid cancer	6.75e-06	7.72e-05	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AKT1—thyroid cancer	5.74e-06	6.57e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.31e-06	6.07e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AKT1—thyroid cancer	4.97e-06	5.69e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTEN—thyroid cancer	4.63e-06	5.3e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AKT1—thyroid cancer	4.33e-06	4.96e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AKT1—thyroid cancer	2.67e-06	3.05e-05	CbGpPWpGaD
